Albumin Corona‐Coated Nanoscale Metal–Organic Framework for Enzyme‐Mediated Cascade Metabolization of Uric Acid in Hyperuricemia
Small · 2025
DOI: 10.1002/smll.202412612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Mingchen Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai, 201804, China. Hauptthemen laut MEDLINE: Uric Acid, Hyperuricemia, Metal-Organic Frameworks, Albumins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission, Shanghai Rising-Star Program.
Abstract (Originalsprache)
Hyperuricemia, characterized by elevated uric acid levels, is the primary cause of gout. Recombinant uricase is one of the last‐resort therapies but generates unwanted pro‐inflammatory H 2 O 2 and anti‐uricase antibodies. In this work, we developed an albumin corona‐coated enzyme‐loaded zeolitic imidazolate framework (UCZIF) to sustainably maintain low blood uric acid level without producing H 2 O 2 . The corona coating not only preserves loaded enzymes but also reduces macrophage phagocytosis by 73.4% compared to free uricase. In addition, the uptake level of UCZIF by dendritic cells is reduced by 74.1%, and the maturation of dendritic cells is inhibited by 35.4% compared to free uricase. Animal experiments demonstrate that albumin corona‐coated UCZIF effectively lowers blood uric acid level in both acute and diet‐induced chronic hyperuricemia models with significantly increasing the half‐life of uricase. Furthermore, compared to the generation of anti‐uricase antibodies during standalone uricase treatment, the levels of anti‐uricase immunoglobulins are significantly reduced by 65.5% (immunoglobulin M) and 76.3% (immunoglobulin G) with repeated administration of albumin corona‐coated UCZIF. Overall, this albumin corona‐coated nanoscale metal–organic framework offers a promising approach to minimize the immunogenicity induced by exogenous enzymes and further safely reduce uric acid levels in the treatment of hyperuricemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai, 201804, China.
- Department of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institu…
- School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237, China.
ORCID-Profile: Zhen Fan
Förderung
- National Natural Science Foundation of China
- Innovation Program of Shanghai Municipal Education Commission
- Shanghai Rising-Star Program
Zitieren
APA
Lv, M., Xu, J., Chen, R., Hu, W., Zhou, Y., Sun, M., Fan, Z., & Du, J. (2025). Albumin Corona‐Coated Nanoscale Metal–Organic Framework for Enzyme‐Mediated Cascade Metabolization of Uric Acid in Hyperuricemia. Small. https://doi.org/10.1002/smll.202412612
Vancouver
Lv M, Xu J, Chen R, Hu W, Zhou Y, Sun M, et al. Albumin Corona‐Coated Nanoscale Metal–Organic Framework for Enzyme‐Mediated Cascade Metabolization of Uric Acid in Hyperuricemia. Small. 2025. doi:10.1002/smll.202412612
BibTeX
@article{Lv2025,
author = {Lv, Mingchen and Xu, Jiaxi and Chen, Ran and Hu, Wei and Zhou, Yuxiao and Sun, Min and Fan, Zhen and Du, Jianzhong},
title = {Albumin Corona‐Coated Nanoscale Metal–Organic Framework for Enzyme‐Mediated Cascade Metabolization of Uric Acid in Hyperuricemia},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202412612}
}
EUVIMED